diagnostic and therapeutic challenges in erythema elevatum diutinum
Przeglad Dermatologiczny, ISSN: 2084-9893, Vol: 110, Issue: 6, Page: 711-715
2023
- 1Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Captures1
- Readers1
Article Description
Introduction: Erythema elevatum diutinum (EED) is a rare form of cutaneous fibrosing type of leukocytoclastic vasculitis leading sometimes to nodule formation, imitating neoplastic process. Case report: We present the case of a 65-year-old woman with a 6-year history of cutaneous presentation of erythema elevatum diutinum, coexisting with myasthenia gravis and monoclonal IgA gammopathy. Dermoscopy of the skin lesions showed prominent thick arborizing vessels in a concentric alignment. Previous treatment with the use of methotrexate, dapsone, mycophenolate mofetil and cyclosporine did not stop the disease progression. Laboratory tests showed the presence of monoclonal protein IgAk in the serum and X-ray examination showed numerous fine-spot thinning of bone structure, especially within the skull bones. Hematological treatment with thalidomide and cyclophosphamide was introduced. A rapid resolution of skin lesions was observed. Conclusions: This case shows that management of the underlying hematological abnormality may be essential for successful therapy of the otherwise treatment resistant erythema elevatum diutinum.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85193301706&origin=inward; http://dx.doi.org/10.5114/dr.2023.138880; https://www.termedia.pl/doi/10.5114/dr.2023.138880; https://dx.doi.org/10.5114/dr.2023.138880; https://www.termedia.pl/Diagnostic-and-therapeutic-challenges-in-erythema-elevatum-diutinum,56,53960,0,1.html
Termedia Sp. z.o.o.
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know